SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?


To: adam hefian who wrote (824)3/23/1998 11:36:00 PM
From: David Cathcart  Read Replies (1) | Respond to of 1826
 
Hi Adam,

Did I detect a little cheer in your post? I hope so. What is my target? I honestly don't have one now. So much is slated to happen over the next few months. Exactly when and how those events unfold, and how the market anticipates and reacts to those events, are things that I don't think anyone can crystal ball. Are your targets unreasonable? IMO not anymore unreasonable than the price of MOGN being at $4.50 a few days ago.

As for me, I'm not attached to the timing of any target event or price point at this time. I'm just enjoying the hell out of this ride. Go MOGN!

David



To: adam hefian who wrote (824)3/24/1998 12:49:00 PM
From: seminole  Respond to of 1826
 
Adam

<<Whats your target if MGI114 moves to Phase2>>

My target is no more tumors. The price will
take care of itself.

Damn, now we got get this stock to $20?
richard